Latest News of CYTK
Cytokinetics, Incorporated (CYTK) Stock Price, News, Quote & History
By Yahoo! Finance |
3 days ago
Bayer has acquired rights to Cytokinetics' heart drug in Japan through a collaboration deal. The agreement includes an upfront payment of 50 million euros with potential additional payments based on d...
Is Cytokinetics Inc. (CYTK) Positioned for Success with Its Innovative Muscle Modulators?
By Yahoo! Finance |
1 month ago
A recent article highlights Cytokinetics Inc. as a promising small-cap stock for investment. It discusses the impact of interest rate cuts on small and mid-cap stocks and provides insights from expert...
Cytokinetics, Incorporated (CYTK) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
2 months ago
Cytokinetics, Inc. shared positive results from the Phase 1 study of CK-4021586 at a medical conference. The study successfully evaluated safety, tolerability, and pharmacokinetics of CK-586, a drug b...
-
Is Cytokinetics, Incorporated (CYTK) a Good Biotech Stock According to Hedge Funds?
By Yahoo! Finance | 2 months agoA compilation of the 12 Best Biotech Stocks To Invest In According To Hedge Funds includes Cytokinetics, Inc. (NASDAQ:CYTK). The biotech industry is forecasted to grow significantly, with AI-driven dr...
-
Investors in Cytokinetics (NASDAQ:CYTK) have seen incredible returns of 381% over the past five years
By Yahoo! Finance | 3 months agoLong term investing in great businesses like Cytokinetics (NASDAQ:CYTK) can lead to significant share price growth, with a 381% gain in the last five years. Despite not being profitable, its 6.7% annu...
-
Insider Sale: EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
By Yahoo! Finance | 4 months agoCytokinetics Inc is a biopharmaceutical company focused on developing therapeutics for muscle-related diseases. Insider Fady Malik sold 131,323 shares, indicating 42 sells and no buys in the past year...
-
Insider Sale: Director B Parshall Sells 5,000 Shares of Cytokinetics Inc (CYTK)
By Yahoo! Finance | 4 months agoCytokinetics Inc is a biopharmaceutical company focusing on developing muscle-modulating therapeutics. Recent insider selling trends and stock valuation indicate potential overvaluation. Investors may...
-
Insider Selling: Director B Parshall Sells Shares of Cytokinetics Inc (CYTK)
By Yahoo! Finance | 5 months agoOn June 17, 2024, B Parshall, Director at Cytokinetics Inc (NASDAQ:CYTK), sold 5,000 shares at $52.55 per share, totaling $262,750. The insider now holds 20,600 shares....
-
Insider Sale at Cytokinetics Inc (CYTK) by EVP of Research & Development
By Yahoo! Finance | 5 months agoFady Malik, Executive VP at Cytokinetics Inc, sold 7,788 shares on June 11, 2024, bringing his total to 135,004 shares. The company focuses on developing muscle function modulating therapeutics....